StockData
TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc. (TCRX) stock

TCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/3089% below fair value
$0.15−0.00 (-1.72%)

Close on Nov 18, 2026Market cap $10.06MP/E –Yield –

TScan Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

TScan Therapeutics's market cap was $24.11M on Nov 11, 2026, against $141.55M a year earlier. Over the last 4 years it ranged from $11.02M to $710.03M, with a median of $140.22M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$24.11M-81.1%
2025Dec 31, 2025$127.52M-60.3%
2024Dec 31, 2024$320.92M+15.7%
2023Dec 29, 2023$277.42M+879.4%
2022Jan 31, 2022$28.33M+7.3%
2021Dec 31, 2021$26.39M–

More TScan Therapeutics figures

See a number that looks wrong?